STOCK TITAN

New York Times SEC Filings

NYT NYSE

Welcome to our dedicated page for New York Times SEC filings (Ticker: NYT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission filings for The New York Times Company (NYSE: NYT), a media company in the newspaper publishers industry. As a public issuer, the company submits current reports, annual and quarterly reports and other required documents that describe its operations, financial condition and governance.

Recent examples include Form 8-K filings in which The New York Times Company reports the release of quarterly financial results. These filings typically reference a press release furnished as an exhibit and identify the information as relating to results of operations and financial condition. Such documents help investors track the timing and content of the company’s official financial disclosures.

On this page, users can review NYT filings such as Form 10-K annual reports, Form 10-Q quarterly reports and Form 8-K current reports, along with other forms that may cover topics like governance or capital structure. For a company organized around the New York Times Group and The Athletic segments, these filings are a primary source for understanding segment-level performance, revenue composition from subscriptions, advertising and other sources, and risk disclosures.

Stock Titan enhances these regulatory documents with AI-powered summaries that explain key sections in plain language, highlight important changes from prior periods and help users navigate lengthy reports. Filings are updated in near real time as they appear on the SEC’s EDGAR system, and users can also locate insider transaction reports on Form 4 and proxy materials on Schedule 14A where available. This combination of raw filings and AI analysis allows investors to review The New York Times Company’s regulatory history and ongoing reporting more efficiently.

Rhea-AI Summary

New York Times Co/The ownership filing: Vanguard Capital Management reported beneficial ownership of 8,201,207 shares of Common Stock, representing 5.11% of the class as of 03/31/2026. The filing lists 1,221,023 shares of sole voting power. The Form is signed 04/30/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

GOLDEN MARGOT reported acquisition or exercise transactions in this Form 4 filing.

New York Times Company director Margot Golden reported a compensation-related grant of 2,277 stock‑settled restricted stock units of Class A Common Stock under the company’s 2020 Incentive Compensation Plan. Each unit represents a contingent right to receive one share of Class A Common Stock.

The units vest on the date of the following Annual Meeting of Stockholders, and vested shares will be delivered within 90 days after Golden’s service on the Board ends. Following this grant, she holds 10,044 Class A shares directly, in addition to indirect holdings held by trusts for which she disclaims beneficial ownership except to any pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

GOLDEN ARTHUR S. reported acquisition or exercise transactions in this Form 4 filing.

New York Times Company director Arthur S. Golden received a grant of 2,277 stock-settled restricted stock units of Class A Common Stock. These units were awarded under The New York Times Company 2020 Incentive Compensation Plan at no cash cost per share.

Each restricted stock unit represents a contingent right to one share of Class A Common Stock and vests on the date of the following Annual Meeting of Stockholders. Vested shares will be delivered within 90 days after Golden’s service on the Board of Directors ends. Following this grant, he holds 22,841 Class A shares directly, with additional indirect holdings reported through trusts and a spouse as trustee.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Glaser Rachel C reported acquisition or exercise transactions in this Form 4 filing.

The New York Times Company director Rachel C. Glaser received an equity grant of 2,277 shares of Class A Common Stock in the form of stock-settled restricted stock units. The grant was made at no cash cost to her as part of director compensation.

Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock and will vest on the date of the company’s next Annual Meeting of Stockholders. After this grant, Glaser holds 35,778 shares directly. Vested shares will be delivered within 90 days after she leaves the Board.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Brooke Beth A. reported acquisition or exercise transactions in this Form 4 filing.

NEW YORK TIMES CO director Beth A. Brooke received a grant of 2,277 Class A share equivalents as equity compensation. The award consists of stock-settled restricted stock units under The New York Times Company 2020 Incentive Compensation Plan, with no cash paid per unit.

Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock and will vest on the date of the following Annual Meeting of Stockholders. After this grant, Brooke directly holds 22,099 Class A shares, and vested shares from this award will be delivered within 90 days after her service on the Board of Directors ends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MCANDREWS BRIAN P reported acquisition or exercise transactions in this Form 4 filing.

NEW YORK TIMES CO director Brian P. McAndrews received equity-based compensation. On April 22, 2026, he was granted 2,277 stock-settled restricted stock units under The New York Times Company 2020 Incentive Compensation Plan, each representing one future share of Class A Common Stock. He also received 165.4378 phantom stock units credited for dividend equivalent payments and accumulated interest under the Non-Employee Directors Deferral Plan. After these awards, he directly holds 59,998 Class A shares and 17,335.9634 phantom stock units, generally distributable after his Board service ends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

ROGERS JOHN W JR reported acquisition or exercise transactions in this Form 4 filing.

NEW YORK TIMES CO director John W. Rogers Jr. received a grant of 2,277 shares of Class A Common Stock in the form of stock-settled restricted stock units under the company’s 2020 Incentive Compensation Plan. After this award, he directly holds 54,492 Class A shares.

Each restricted stock unit represents a contingent right to one share and will vest on the date of the next Annual Meeting of Stockholders. The vested shares will be delivered within 90 days after Rogers’ service on the Board of Directors ends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Subramanian Anuradha B. reported acquisition or exercise transactions in this Form 4 filing.

New York Times Company director Anuradha B. Subramanian received an equity award linked to the company’s Class A Common Stock. The grant covers 2,277 stock-settled restricted stock units under the 2020 Incentive Compensation Plan, with each unit representing a contingent right to one share.

The restricted stock units vest on the date of the following Annual Meeting of Stockholders. Any vested shares will be delivered within 90 days after Subramanian’s service on the Board of Directors ends. Following this award, she directly holds 11,899 Class A Common Stock-related units and shares in total.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Bronstein Manuel reported acquisition or exercise transactions in this Form 4 filing.

New York Times Company director Manuel Bronstein received an equity award rather than buying shares on the market. He was granted 2,277 stock-settled restricted stock units, each representing a contingent right to one share of Class A Common Stock. After this grant, he directly holds 20,343 shares. The units vest on the date of the following Annual Meeting of Stockholders, with vested shares to be delivered within 90 days after he leaves the Board of Directors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Bhutani Amanpal Singh reported acquisition or exercise transactions in this Form 4 filing.

Director Amanpal Singh Bhutani of The New York Times Company received a grant of 2,277 shares of Class A Common Stock in the form of stock-settled restricted stock units under the company’s 2020 Incentive Compensation Plan. These units were awarded at no cash purchase price.

Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The units vest on the date of the following Annual Meeting of Stockholders, and the vested shares will be delivered within 90 days after Bhutani’s service on the Board of Directors ends. Following this award, he directly holds 32,049 shares of Class A Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many New York Times (NYT) SEC filings are available on StockTitan?

StockTitan tracks 97 SEC filings for New York Times (NYT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for New York Times (NYT)?

The most recent SEC filing for New York Times (NYT) was filed on April 30, 2026.